- IP hearings this week
- IP trials
- IP Judicial review hearings
- IP appeals at the Federal Court of Appeal
(As published on the Federal Court and Federal Court of Appeal websites on Sep 29, 2023 at 00:00:00)
This week in IP
| Date | File No. | Type | Name | Location | Length |
| Oct 3, 2023 | T-1511-22 | CMC | Louis Vuitton Malletier Et Al. V. Juvilyn Billones Aka Juvilyn Ward Aka Lyn (Trade Mark) | Toronto | 30 m |
| Oct 4, 2023 | T-877-22 | CMC | Sea Tow Services International, Inc. V. C-tow Marine Assistance Ltd. (Trade Mark) | Toronto | 30 m |
| Oct 4, 2023 | T-901-22 | CMC | C-tow Marine Assistance Ltd. V. Sea Tow Services International, Inc. (Trade Mark) | Toronto | 30 m |
| Oct 4, 2023 | T-1429-21 | M | Liquidpower Specialty Products Inc. V. Baker Hughes Canada Company Et Al. (Patent) | Toronto | 1 d |
| Oct 4, 2023 | T-1484-21 | JR | Vermillion Networks Inc. V. Essilor Group Canada Inc. (Trade Mark - JR) | Calgary | 1 d |
| Oct 4, 2023 | T-599-23 | JR | Apple Inc. V. Gang Cao (Trade Mark - JR) | Toronto | 3 h |
| Oct 4, 2023 | T-786-21 | M | Flowchem Llc V. Liquidpower Specialty Products Inc. (Patent) | Toronto | 1 d |
| Oct 5, 2023 | T-1062-21 | CMC | Millennium Funding, Inc. Et Al. V. Bell Canada Et Al. (Copyright) | Ottawa | 1 h |
| Oct 5, 2023 | T-17-16 | CMC | Ducks Lane Ltd. Et Al. V. Outfront Media Llc Et Al. (Trade Mark) | Toronto | 1 h |
| Oct 6, 2023 | T-151-22 | M | Takeda Canada V. Apotex, Takeda Pharmaceutical Co & Takeda Pharma Usa (Patent - Dexlansoprazole*) | Toronto | 3 h |
Return to top.
Scheduled IP Trials
| Date | File No. | Name | Location | Length |
| Oct 16, 2023 | T-151-22 | Takeda Canada V. Apotex, Takeda Pharmaceutical Co & Takeda Pharma Usa (Patent - Dexlansoprazole*) | Toronto | 10 d |
| Nov 8, 2023 | T-151-22 | Takeda Canada V. Apotex, Takeda Pharmaceutical Co & Takeda Pharma Usa (Patent - Dexlansoprazole*) | Toronto | 2 d |
| Nov 20, 2023 | T-1386-21 | Jcai Inc. V. Wiseleap Solutions Inc. Et Al (Patent) | Montréal | 12 d |
| Nov 20, 2023 | T-919-21 | Maoz Betser-zilevitch V. Canadian Natural Resources Ltd. (Patent) | Toronto | 5 d |
| Dec 1, 2023 | T-919-21 | Maoz Betser-zilevitch V. Canadian Natural Resources Ltd. (Patent) | Toronto | 1 d |
| Jan 8, 2024 | T-1006-22 | Gilead Sciences, Inc. Et Al V. Apotex Inc. (Trade Mark - Tenofovir*) | Toronto | 13 d |
| Jan 8, 2024 | T-1004-22 | Gilead Sciences, Inc. Et Al V. Apotex Inc. (Patent - Tenofovir*) | Toronto | 13 d |
| Jan 29, 2024 | T-802-20 | Eis Inc. V. Wow Tech Canada Ltd. (Patent) | Ottawa | 10 d |
| Jan 29, 2024 | T-118-19 | Unilin Beheer B.v. Et Al V. Floors@work Inc. Et Al (Patent) | Toronto | 13 d |
| Feb 5, 2024 | T-1006-22 | Gilead Sciences, Inc. Et Al V. Apotex Inc. (Trade Mark - Tenofovir*) | Toronto | 2 d |
| Feb 5, 2024 | T-1004-22 | Gilead Sciences, Inc. Et Al V. Apotex Inc. (Patent - Tenofovir*) | Toronto | 2 d |
| Feb 12, 2024 | T-953-17 | The Estate Of Vivian Maier V. Stephen M.bulger Et Al. (Copyright) | Toronto | 2 d |
| Feb 12, 2024 | T-997-22 | Janssen Pharmaceutica N. V. V. Apotex Inc. (Patent - Rilpivirine*) | Toronto | 7 d |
| Feb 14, 2024 | T-802-20 | Eis Inc. V. Wow Tech Canada Ltd. (Patent) | Ottawa | 2 d |
| Feb 15, 2024 | T-953-17 | The Estate Of Vivian Maier V. Stephen M.bulger Et Al. (Copyright) | Toronto | 2 d |
| Feb 22, 2024 | T-953-17 | The Estate Of Vivian Maier V. Stephen M.bulger Et Al. (Copyright) | Toronto | 2 d |
| Feb 22, 2024 | T-997-22 | Janssen Pharmaceutica N. V. V. Apotex Inc. (Patent - Rilpivirine*) | Toronto | 2 d |
| Feb 22, 2024 | T-118-19 | Unilin Beheer B.v. Et Al V. Floors@work Inc. Et Al (Patent) | Toronto | 1.2 d |
| Mar 4, 2024 | T-1241-22 | Bayer Inc. Et Al V. Bgp Pharma Ulc Et Al (Patent - Aflibercept*) | Toronto | 10 d |
| Mar 4, 2024 | T-1484-22 | Gilead Sciences, Inc. Et Al. V. Jamp Pharma Corporation (Patent - Tenofovir*) | Toronto | 10 d |
| Mar 4, 2024 | T-1607-22 | Gilead Sciences, Inc. Et Al. V. Jamp Pharma Corporaton (Patent - Tenofovir*) | Toronto | 10 d |
| Mar 18, 2024 | T-1121-22 | Janssen Inc. Et Al V. Apotex Inc. (Patent - Paliperidone*) | Toronto | 5 d |
| Mar 18, 2024 | T-1122-22 | Janssen Inc. Et Al V. Apotex Inc. (Patent - Paliperidone*) | Toronto | 5 d |
| Mar 18, 2024 | T-1248-22 | Janssen Inc. Et Al. V. Apotex Inc. (Patent - Paliperidone*) | Toronto | 5 d |
| Mar 18, 2024 | T-1249-22 | Janssen Inc. Et Al. V. Apotex Inc. (Patent - Paliperidone*) | Toronto | 5 d |
| Mar 25, 2024 | T-1484-22 | Gilead Sciences, Inc. Et Al. V. Jamp Pharma Corporation (Patent - Tenofovir*) | Toronto | 2 d |
| Mar 25, 2024 | T-1607-22 | Gilead Sciences, Inc. Et Al. V. Jamp Pharma Corporaton (Patent - Tenofovir*) | Toronto | 2 d |
| Apr 8, 2024 | T-1556-22 | Gilead Sciences, Inc. Et Al. V. Natco Pharma (canada) Inc. (Patent - Tenofovir*) | Toronto | 9 d |
| Apr 8, 2024 | T-1555-22 | Gilead Sciences, Inc. Et Al. V. Natco Pharma (canada), Inc. (Patent - Tenofovir*) | Toronto | 9 d |
| Apr 26, 2024 | T-1556-22 | Gilead Sciences, Inc. Et Al. V. Natco Pharma (canada) Inc. (Patent - Tenofovir*) | Toronto | 1 d |
| Apr 26, 2024 | T-1555-22 | Gilead Sciences, Inc. Et Al. V. Natco Pharma (canada), Inc. (Patent - Tenofovir*) | Toronto | 1 d |
| Apr 29, 2024 | T-330-16 | Richard Ivey School Of Business Foundation V. Shih-fen S. Chen (Copyright) | Toronto | 6 d |
| May 6, 2024 | T-1471-21 | Ge Renewable Energy Canada Inc V. Canmec Industrial Inc. (Copyright) | To be determined (TrialJA) | 10 d |
| May 6, 2024 | T-1563-22 | Boehringer Ingelheim(canada) Ltd Et Al V. Jamp Pharma Corp. (Patent - Nintedanib*) | Toronto | 10 d |
| May 7, 2024 | T-1750-22 | Actelion Pharmaceuticals Ltd Et Al. V. Sandoz Canada Inc. (Patent - Selexipag*) | Toronto | 9 d |
| May 10, 2024 | T-330-16 | Richard Ivey School Of Business Foundation V. Shih-fen S. Chen (Copyright) | Toronto | 1 d |
| May 13, 2024 | T-2029-22 | Bayer Inc Et Al V. Bgp Pharma Ulc(viatris Canada) (Patent - Aflibercept*) | Toronto | 5 d |
| May 24, 2024 | T-1750-22 | Actelion Pharmaceuticals Ltd Et Al. V. Sandoz Canada Inc. (Patent - Selexipag*) | Toronto | 1 d |
| May 27, 2024 | T-1842-22 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Sun Pharma Canada Inc. (Patent - Empagliflozin*) | To be determined (TrialJA) | 20 d |
| May 27, 2024 | T-1563-22 | Boehringer Ingelheim(canada) Ltd Et Al V. Jamp Pharma Corp. (Patent - Nintedanib*) | Toronto | 2 d |
| May 27, 2024 | T-1838-22 | Amgen Canada Inc. Et Al. V. Sandoz Canada Inc. (Patent - Carfilzomib*) | Toronto | 12 d |
| May 27, 2024 | T-1831-22 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Sandoz Canada Inc. (Patent - Empagliflozin*) | To be determined (TrialJA) | 20 d |
| Jun 14, 2024 | T-1838-22 | Amgen Canada Inc. Et Al. V. Sandoz Canada Inc. (Patent - Carfilzomib*) | Toronto | 6 d |
| Jun 17, 2024 | T-1449-20 | Proslide Technology, Inc. V. Whitewater West Industries, Ltd. (Patent) | To be determined (TrialJA) | 10 d |
| Jun 25, 2024 | T-1842-22 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Sun Pharma Canada Inc. (Patent - Empagliflozin*) | To be determined (TrialJA) | 3 d |
| Jun 25, 2024 | T-1831-22 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Sandoz Canada Inc. (Patent - Empagliflozin*) | To be determined (TrialJA) | 3 d |
| Jul 2, 2024 | T-1838-22 | Amgen Canada Inc. Et Al. V. Sandoz Canada Inc. (Patent - Carfilzomib*) | Toronto | 2 d |
| Jul 3, 2024 | T-1449-20 | Proslide Technology, Inc. V. Whitewater West Industries, Ltd. (Patent) | To be determined (TrialJA) | 3 d |
| Jul 15, 2024 | T-2276-22 | Boehringer Ingelheim (canada) Ltd Et Al. V. Jamp Pharma Corporation (Patent - Empagliflozin*) | To be determined (TrialJA) | 10 d |
| Jul 15, 2024 | T-2318-22 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Jamp Pharma Corporation (Patent - Empagliflozin*) | To be determined (TrialJA) | 10 d |
| Aug 12, 2024 | T-2276-22 | Boehringer Ingelheim (canada) Ltd Et Al. V. Jamp Pharma Corporation (Patent - Empagliflozin*) | To be determined (TrialJA) | 10 d |
| Aug 12, 2024 | T-2318-22 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Jamp Pharma Corporation (Patent - Empagliflozin*) | To be determined (TrialJA) | 10 d |
| Aug 12, 2024 | T-2133-22 | Gilead Sciences, Inc. Et Al V. Pharmascience Inc. (Patent - Tenofovir*) | Toronto | 10 d |
| Aug 12, 2024 | T-2139-22 | Gilead Sciences, Inc. Et Al V. Pharmascience Inc. (Patent - Tenofovir*) | Toronto | 10 d |
| Aug 28, 2024 | T-2276-22 | Boehringer Ingelheim (canada) Ltd Et Al. V. Jamp Pharma Corporation (Patent - Empagliflozin*) | To be determined (TrialJA) | 3 d |
| Aug 28, 2024 | T-2318-22 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Jamp Pharma Corporation (Patent - Empagliflozin*) | To be determined (TrialJA) | 3 d |
| Aug 29, 2024 | T-2133-22 | Gilead Sciences, Inc. Et Al V. Pharmascience Inc. (Patent - Tenofovir*) | Toronto | 2 d |
| Aug 29, 2024 | T-2139-22 | Gilead Sciences, Inc. Et Al V. Pharmascience Inc. (Patent - Tenofovir*) | Toronto | 2 d |
| Sep 9, 2024 | T-754-22 | Sandvik Mining And Construction Oy And Sandvik Canada Inc. V. Epiroc Canada (Patent) | Toronto | 8 d |
| Sep 9, 2024 | T-310-20 | Jeff Chesebrough Et Al V. Innereco Environmental Inc. Et Al (Patent) | Toronto | 7 d |
| Sep 9, 2024 | T-435-22 | Australian Mud Company Pty Ltd Et Al. V. Boart Longyear Group Inc. Et Al. (Patent) | Toronto | 10 d |
| Sep 16, 2024 | T-2582-22 | Novartis Pharmaceuticals Canada Inc. Et Al. V. Pharmascience Inc. (Patent) | Montréal | 10 d |
| Sep 16, 2024 | T-86-23 | Guardtek Systems Inc. Et Al. V. Guardteck Security Corp. Et Al. (unknown) | Toronto | 10 d |
| Sep 19, 2024 | T-328-22 | Kerry Group Services International, Ltd. Et Al. V. Florida Food Products, Ll (Patent) | To be determined (TrialJA) | 7 d |
| Sep 20, 2024 | T-310-20 | Jeff Chesebrough Et Al V. Innereco Environmental Inc. Et Al (Patent) | Toronto | 1 d |
| Sep 25, 2024 | T-754-22 | Sandvik Mining And Construction Oy And Sandvik Canada Inc. V. Epiroc Canada (Patent) | Toronto | 2 d |
| Oct 1, 2024 | T-192-23 | Boehringer Ingelheim (canada) Ltd Et Al V. Laboratoire Riva Inc. (Patent - Linagliptin*) | Toronto | 9 d |
| Oct 1, 2024 | T-191-23 | Boehringer Ingelheim (canada) Ltd Et Al V. Laboratoire Riva Inc. (Patent) | Toronto | 9 d |
| Oct 1, 2024 | T-193-23 | Boehringer Ingelheim (canada) Ltd Et Al V. Laboratoire Riva Inc. (Patent - Linagliptin*) | Toronto | 9 d |
| Oct 1, 2024 | T-194-23 | Boehringer Ingelheim (canada) Ltd Et Al V. Laboratoire Riva Inc (Patent - Linagliptin*) | Toronto | 9 d |
| Oct 1, 2024 | T-195-23 | Boehringer Ingelheim (canada) Ltd Et Al V. Laboratoire Riva Inc (Patent - Linagliptin*) | Toronto | 9 d |
| Oct 1, 2024 | T-196-23 | Boehringer Ingelheim (canada) Ltd. Et Al V. Laboratoire Riva Inc. (Patent - Linagliptin*) | Toronto | 9 d |
| Oct 1, 2024 | T-197-23 | Boehringer Ingelheim (canada)ltd Et Al V. Laboratoire Riva Inc. (Patent - Linagliptin*) | Toronto | 9 d |
| Oct 2, 2024 | T-2582-22 | Novartis Pharmaceuticals Canada Inc. Et Al. V. Pharmascience Inc. (Patent) | Montréal | 2 d |
| Oct 15, 2024 | T-328-22 | Kerry Group Services International, Ltd. Et Al. V. Florida Food Products, Ll (Patent) | To be determined (TrialJA) | 1 d |
| Oct 21, 2024 | T-192-23 | Boehringer Ingelheim (canada) Ltd Et Al V. Laboratoire Riva Inc. (Patent - Linagliptin*) | Toronto | 4 d |
| Oct 21, 2024 | T-191-23 | Boehringer Ingelheim (canada) Ltd Et Al V. Laboratoire Riva Inc. (Patent) | Toronto | 4 d |
| Oct 21, 2024 | T-193-23 | Boehringer Ingelheim (canada) Ltd Et Al V. Laboratoire Riva Inc. (Patent - Linagliptin*) | Toronto | 4 d |
| Oct 21, 2024 | T-194-23 | Boehringer Ingelheim (canada) Ltd Et Al V. Laboratoire Riva Inc (Patent - Linagliptin*) | Toronto | 4 d |
| Oct 21, 2024 | T-195-23 | Boehringer Ingelheim (canada) Ltd Et Al V. Laboratoire Riva Inc (Patent - Linagliptin*) | Toronto | 4 d |
| Oct 21, 2024 | T-196-23 | Boehringer Ingelheim (canada) Ltd. Et Al V. Laboratoire Riva Inc. (Patent - Linagliptin*) | Toronto | 4 d |
| Oct 21, 2024 | T-197-23 | Boehringer Ingelheim (canada)ltd Et Al V. Laboratoire Riva Inc. (Patent - Linagliptin*) | Toronto | 4 d |
| Oct 21, 2024 | T-269-23 | Novartis Pharmaceuticals Canada Inc. Et Al. V. Apotex Inc. (Patent - Nilotinib*) | To be determined (TrialJA) | 8 d |
| Oct 28, 2024 | T-641-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc. (Patent - Empagliflozin*) | To be determined (TrialJA) | 16 d |
| Oct 30, 2024 | T-192-23 | Boehringer Ingelheim (canada) Ltd Et Al V. Laboratoire Riva Inc. (Patent - Linagliptin*) | Toronto | 2 d |
| Oct 30, 2024 | T-191-23 | Boehringer Ingelheim (canada) Ltd Et Al V. Laboratoire Riva Inc. (Patent) | Toronto | 2 d |
| Oct 30, 2024 | T-193-23 | Boehringer Ingelheim (canada) Ltd Et Al V. Laboratoire Riva Inc. (Patent - Linagliptin*) | Toronto | 2 d |
| Oct 30, 2024 | T-194-23 | Boehringer Ingelheim (canada) Ltd Et Al V. Laboratoire Riva Inc (Patent - Linagliptin*) | Toronto | 2 d |
| Oct 30, 2024 | T-196-23 | Boehringer Ingelheim (canada) Ltd. Et Al V. Laboratoire Riva Inc. (Patent - Linagliptin*) | Toronto | 2 d |
| Oct 30, 2024 | T-195-23 | Boehringer Ingelheim (canada) Ltd Et Al V. Laboratoire Riva Inc (Patent - Linagliptin*) | Toronto | 2 d |
| Oct 30, 2024 | T-197-23 | Boehringer Ingelheim (canada)ltd Et Al V. Laboratoire Riva Inc. (Patent - Linagliptin*) | Toronto | 2 d |
| Nov 6, 2024 | T-269-23 | Novartis Pharmaceuticals Canada Inc. Et Al. V. Apotex Inc. (Patent - Nilotinib*) | To be determined (TrialJA) | 2 d |
| Nov 12, 2024 | T-1477-22 | Pfizer Canada Ulc And Pfizer Inc. V. Amgen Research (munich) Gmbh And Amgen (Patent - Elranatamab*) | Toronto | 9 d |
| Nov 25, 2024 | T-641-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc. (Patent - Empagliflozin*) | To be determined (TrialJA) | 3 d |
| Nov 27, 2024 | T-1477-22 | Pfizer Canada Ulc And Pfizer Inc. V. Amgen Research (munich) Gmbh And Amgen (Patent - Elranatamab*) | Toronto | 1 d |
| Nov 28, 2024 | T-1766-22 | Bayer Inc. Et Al V. Bgp Pharma Ulc D.b.a. Viatris Canada (Patent - Aflibercept*) | Toronto | 10 d |
| Nov 28, 2024 | T-1482-22 | Bayer Inc. Et Al. V. Bgp Pharma Ulc D.b.a. Viatris Canada Et Al. (Patent - Aflibercept*) | Toronto | 10 d |
| Dec 18, 2024 | T-1766-22 | Bayer Inc. Et Al V. Bgp Pharma Ulc D.b.a. Viatris Canada (Patent - Aflibercept*) | Toronto | 2 d |
| Dec 18, 2024 | T-1482-22 | Bayer Inc. Et Al. V. Bgp Pharma Ulc D.b.a. Viatris Canada Et Al. (Patent - Aflibercept*) | Toronto | 2 d |
| Jan 13, 2025 | T-841-21 | Adeia Guides, Inc. V. Videotron Ltd. (Patent) | Toronto | 15 d |
| Jan 20, 2025 | T-1095-23 | Alexion Pharmaceuticals, Inc. Et Al V. Amgen Canada Inc. (Patent - Eculizumab*) | Toronto | 13 d |
| Jan 20, 2025 | T-1094-23 | Alexion Pharmaceuticals, Inc. Et Al V. Amgen Canada Inc. (Patent - Eculizumab*) | Toronto | 13 d |
| Jan 27, 2025 | T-1506-20 | Meridian Manufacturing Inc. V. Concept Industries Ltd. (Patent) | Winnipeg | 7 d |
| Feb 3, 2025 | T-1040-23 | Otsuka Pharmaceutical Co. Ltd V. Teva Canada Limited (Patent - Brexpiprazole*) | Toronto | 8 d |
| Feb 10, 2025 | T-841-21 | Adeia Guides, Inc. V. Videotron Ltd. (Patent) | Toronto | 3 d |
| Feb 13, 2025 | T-1095-23 | Alexion Pharmaceuticals, Inc. Et Al V. Amgen Canada Inc. (Patent - Eculizumab*) | Toronto | 2 d |
| Feb 13, 2025 | T-1094-23 | Alexion Pharmaceuticals, Inc. Et Al V. Amgen Canada Inc. (Patent - Eculizumab*) | Toronto | 2 d |
| Feb 17, 2025 | T-1287-23 | Janssen Inc. Et Al. V. Sandoz Canada Inc. (Patent - Macitentan*) | Toronto | 5 d |
| Feb 20, 2025 | T-1040-23 | Otsuka Pharmaceutical Co. Ltd V. Teva Canada Limited (Patent - Brexpiprazole*) | Toronto | 1 d |
| Feb 27, 2025 | T-1287-23 | Janssen Inc. Et Al. V. Sandoz Canada Inc. (Patent - Macitentan*) | Toronto | 1 d |
| Mar 3, 2025 | T-1039-23 | Emd Serono, A Division Of Emd Inc., Canada Et Al. V. Apotex Inc. (Patent) | Toronto | 8 d |
| Mar 20, 2025 | T-1039-23 | Emd Serono, A Division Of Emd Inc., Canada Et Al. V. Apotex Inc. (Patent) | Toronto | 1 d |
| Apr 28, 2025 | T-1730-23 | Otsuka Pharmaceutical Co., Ltd V. Jamp Pharma Corporation (Patent) | Toronto | 9 d |
| Apr 28, 2025 | T-1731-23 | Otsuka Pharmaceutical Co., Ltd V. Jamp Phamra Corporation (Patent) | Toronto | 9 d |
| Apr 28, 2025 | T-1288-18 | Gemak Trust V. Jempak Corporation Et Al (Patent) | Ottawa | 15 d |
| Apr 28, 2025 | T-1184-21 | Adeia Guides, Inc. Et Al. V. Bce Inc. Et Al. (Patent) | Toronto | 21 d |
| May 5, 2025 | T-2118-22 | Pfizer Canada Ulc Et Al V. Uniqure Biopharma B.v (unknown - Fidanacogene*) | To be determined (TrialJA) | 10 d |
| May 15, 2025 | T-1730-23 | Otsuka Pharmaceutical Co., Ltd V. Jamp Pharma Corporation (Patent) | Toronto | 1 d |
| May 15, 2025 | T-1731-23 | Otsuka Pharmaceutical Co., Ltd V. Jamp Phamra Corporation (Patent) | Toronto | 1 d |
| May 26, 2025 | T-1288-18 | Gemak Trust V. Jempak Corporation Et Al (Patent) | Ottawa | 3 d |
| May 26, 2025 | T-732-22 | Pharmascience Inc. V. Janssen Inc. Et Al. (PMNOC - Section 8 - Abiraterone*) | Toronto | 10 d |
| Jun 2, 2025 | T-1184-21 | Adeia Guides, Inc. Et Al. V. Bce Inc. Et Al. (Patent) | Toronto | 3 d |
| Jun 12, 2025 | T-732-22 | Pharmascience Inc. V. Janssen Inc. Et Al. (PMNOC - Section 8 - Abiraterone*) | Toronto | 1 d |
| Oct 27, 2025 | T-932-23 | Boehringer Ingelheim (canada) Ltd. Et Al V. Glenmark Pharmaceuticals Ca. Inc (Patent) | Toronto | 8 d |
| Nov 12, 2025 | T-932-23 | Boehringer Ingelheim (canada) Ltd. Et Al V. Glenmark Pharmaceuticals Ca. Inc (Patent) | Toronto | 2 d |
| Jan 19, 2026 | T-1336-23 | Boehringer Ingelheim (canada Ltd.) Et Al. V. Auro Pharma Inc. (Patent - Nintedanib*) | Toronto | 10 d |
| Feb 5, 2026 | T-1336-23 | Boehringer Ingelheim (canada Ltd.) Et Al. V. Auro Pharma Inc. (Patent - Nintedanib*) | Toronto | 2 d |
Return to top.
Scheduled Judicial Review Hearings
| Date | File No. | Name | Type | Location | Length |
| Oct 4, 2023 | T-1484-21 | Vermillion Networks Inc. V. Essilor Group Canada Inc. | Trade Mark - Appeal of a decision of the Registrar | Calgary | 1 d |
| Oct 4, 2023 | T-599-23 | Apple Inc. V. Gang Cao | Trade Mark - Appeal of a decision of the Registrar | Toronto | 3 h |
| Oct 17, 2023 | T-1902-21 | Bayer Inc. V. The Minister Of Health Et Al. | S. 18.1 Application for Judicial Review | Toronto | 1 d |
| Nov 21, 2023 | T-2449-22 | Mosaiq Inc. Et Al. V. Clark Wilson Llp | Trade Mark - Appeal of a decision of the Registrar | Montréal | 2 h |
| Nov 22, 2023 | T-906-20 | Galderma Canada Inc. V. Attorney General Of Canada | S. 18.1 Application for Judicial Review | Toronto | 1 d |
| Nov 23, 2023 | T-2544-22 | Blaze Pizza, Llc V Carbone Restaurant Group Ltd | Trade Mark - Appeal of a decision of the Registrar | Toronto | 3 h |
| Nov 23, 2023 | T-2485-22 | D.m.c. Srl V. Ermenegildo Giusti | Trade Mark - Appeal of a decision of the Registrar | Toronto | 1 d |
| Nov 28, 2023 | T-1334-22 | Finastra International Limited V. Fenestrae B.v. | Trade Mark - Appeal of a decision of the Registrar | Toronto | 1 d |
| Dec 12, 2023 | T-1625-22 | Pdm Parthian Distributer & Marketing Adviser Gmbh V. Brewdog Plc | Trade Mark - Appeal of a decision of the Registrar | Toronto | 3 h |
| Dec 12, 2023 | T-270-23 | Puma Se V. Caterpillar Inc. | Trade Mark - Appeal of a decision of the Registrar | Toronto | 3 h |
Return to top.
Scheduled IP Appeals
| Date | File No. | Name | Type | Location |
| Oct 3, 2023 | A-131-22 | Apotex Inc. V. Janssen Inc. Et Al | Appeal (S.27 - Final) - Others | Toronto |
| Oct 4, 2023 | A-128-22 | Sandoz Canada Inc. V. Janssen Inc. Et Al. | Appeal (S.27 - Final) - Others | Toronto |
| Oct 25, 2023 | A-202-22 | Dragona Carpet Supplies Mississauga Inc V. Dragona Carpet Supplies Ltd Et Al | Appeal (S.27 - Final) - Trade-marks Act [from T-751-21 - Trade Mark - Passing Off] | Ottawa |
* Medicinal ingredients are based on automated analysis and should not be relied upon.
Return to top.